AR049349A1 - Metodo para la preparacion de acidos hidroxamicos - Google Patents
Metodo para la preparacion de acidos hidroxamicosInfo
- Publication number
- AR049349A1 AR049349A1 ARP050102314A ARP050102314A AR049349A1 AR 049349 A1 AR049349 A1 AR 049349A1 AR P050102314 A ARP050102314 A AR P050102314A AR P050102314 A ARP050102314 A AR P050102314A AR 049349 A1 AR049349 A1 AR 049349A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- group
- preparation
- independently selected
- hydroxamic acids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/12—1,4-Thiazines; Hydrogenated 1,4-thiazines not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Reivindicacion 1: Un proceso para la preparacion de un compuesto de la formula (1): que comprende la reaccion de un éster silílico del ácido (3S)-2,3-dimetil-tetrahidro-2H-1,4-tiazin-3-carboxílico, con un compuesto de la formula (2) en la cual: J es seleccionado del grupo contituido por Cl, Br, F, 1,2,4-triazolilo, benzotriazolilo e imidazolilo, cada uno de R1 y R2 es independientemente seleccionado del grupo constituido por H, alquilo C1-6 o -CCH; cada uno de R3 y R4 es independientemente seleccionado del grupo constituido por H y alquilo C1-6; R5 es seleccionado del grupo constituido por H, -C(O)-alquilo C1-6, -C(O)-cicloalquilo C3-6, -C(O)-arilo, -C(O)-heteroarilo, -C(O)O-alquilo C1-6, -C(O)O-arilo y SiR6R7R8, y cada uno de R6, R7 y R8 es independientemente seleccionado del grupo constituido por alquilo C1-6 y fenilo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57778404P | 2004-06-08 | 2004-06-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR049349A1 true AR049349A1 (es) | 2006-07-19 |
Family
ID=35106941
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP050102315A AR049073A1 (es) | 2004-06-08 | 2005-06-07 | Polimorfos cristalinos de (3s)-n-hidroxi-4-({4-[(4-hidroxi-2-butinil)oxi]fenil}sulfonil)-2,2-dimetil-3-tiomorfolina carboxamida |
ARP050102314A AR049349A1 (es) | 2004-06-08 | 2005-06-07 | Metodo para la preparacion de acidos hidroxamicos |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP050102315A AR049073A1 (es) | 2004-06-08 | 2005-06-07 | Polimorfos cristalinos de (3s)-n-hidroxi-4-({4-[(4-hidroxi-2-butinil)oxi]fenil}sulfonil)-2,2-dimetil-3-tiomorfolina carboxamida |
Country Status (6)
Country | Link |
---|---|
US (2) | US7435732B2 (es) |
AR (2) | AR049073A1 (es) |
GT (1) | GT200500139A (es) |
PA (2) | PA8636101A1 (es) |
TW (2) | TW200612959A (es) |
WO (2) | WO2005123705A1 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL1682537T3 (pl) | 2003-11-05 | 2012-09-28 | Sarcode Bioscience Inc | Modulatory adhezji komórkowej |
GT200500139A (es) * | 2004-06-08 | 2005-07-25 | Metodo para la preparacion de acidos hidroxamicos | |
CA2609053C (en) | 2005-05-17 | 2017-04-25 | Sarcode Corporation | Compositions and methods for treatment of eye disorders |
FR2898497B1 (fr) * | 2006-03-20 | 2008-05-16 | Galderma Res & Dev | Utilisation de l'apratastat ou du (s)-n-hydroxy-4-(4-but-2- ynyloxy-benzenesulfonyl)-2,2-dimethyl-thiomorpholine-3-carbo xamide dans le traitement de pathologies inflammatoires cutanees |
US7631568B2 (en) * | 2007-08-28 | 2009-12-15 | Quest Technologies | Particulate monitor |
EP3797775A1 (en) | 2007-10-19 | 2021-03-31 | Novartis AG | Compositions and methods for treatment of diabetic retinopathy |
US8080562B2 (en) | 2008-04-15 | 2011-12-20 | Sarcode Bioscience Inc. | Crystalline pharmaceutical and methods of preparation and use thereof |
US8378105B2 (en) | 2009-10-21 | 2013-02-19 | Sarcode Bioscience Inc. | Crystalline pharmaceutical and methods of preparation and use thereof |
US8865937B2 (en) | 2009-11-06 | 2014-10-21 | Mahendra G. Dedhiya | Crystalline forms of (1S,2R)-2-(amino methyl)-N,N-diethyl-1-phenyl cyclopropane carboxamide |
CN104797574B (zh) | 2012-07-25 | 2019-11-22 | 原生质生物科学股份有限公司 | Lfa-1抑制剂及其多晶型物 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP9902092A3 (en) | 1995-12-08 | 2000-12-28 | Agouron Pharmaceuticals Inc La | Metalloproteinase inhibitor benzenesulfonamide derivatives, intermediates, preparation and use thereof, pharmaceutical compositions containing these compounds |
JP3710489B2 (ja) | 1997-02-11 | 2005-10-26 | ファイザー・インク | アリールスルホニルヒドロキサム酸誘導体 |
US6225311B1 (en) | 1999-01-27 | 2001-05-01 | American Cyanamid Company | Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
US6387901B1 (en) | 1999-07-06 | 2002-05-14 | Pfizer Inc | Alkyne containing metalloproteinase inhibitors |
CA2357110A1 (en) * | 2001-04-11 | 2002-10-11 | American Cyanamid Company | Method for the treatment of polycystic kidney disease |
CA2464727A1 (en) | 2001-11-01 | 2003-05-08 | Wyeth Holdings Corporation | Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors |
GT200500139A (es) | 2004-06-08 | 2005-07-25 | Metodo para la preparacion de acidos hidroxamicos |
-
2005
- 2005-06-06 GT GT200500139A patent/GT200500139A/es unknown
- 2005-06-07 US US11/146,730 patent/US7435732B2/en not_active Expired - Fee Related
- 2005-06-07 US US11/146,723 patent/US7179911B2/en not_active Expired - Fee Related
- 2005-06-07 WO PCT/US2005/020014 patent/WO2005123705A1/en active Application Filing
- 2005-06-07 AR ARP050102315A patent/AR049073A1/es unknown
- 2005-06-07 WO PCT/US2005/020065 patent/WO2005123706A1/en active Application Filing
- 2005-06-07 AR ARP050102314A patent/AR049349A1/es unknown
- 2005-06-07 TW TW094118745A patent/TW200612959A/zh unknown
- 2005-06-07 TW TW094118744A patent/TW200610523A/zh unknown
- 2005-06-08 PA PA20058636101A patent/PA8636101A1/es unknown
- 2005-06-08 PA PA20058636301A patent/PA8636301A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
US7179911B2 (en) | 2007-02-20 |
US20050272928A1 (en) | 2005-12-08 |
AR049073A1 (es) | 2006-06-21 |
PA8636101A1 (es) | 2006-03-24 |
WO2005123706A9 (en) | 2006-04-27 |
PA8636301A1 (es) | 2006-03-24 |
US7435732B2 (en) | 2008-10-14 |
WO2005123706A1 (en) | 2005-12-29 |
GT200500139A (es) | 2005-07-25 |
WO2005123705A1 (en) | 2005-12-29 |
TW200612959A (en) | 2006-05-01 |
TW200610523A (en) | 2006-04-01 |
US20050272929A1 (en) | 2005-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR049349A1 (es) | Metodo para la preparacion de acidos hidroxamicos | |
EP1914231A3 (de) | 2-Methyl-2-alkenyl-substituierte 1,3-Dioxane als Riechstoffe | |
ECSP003828A (es) | Antagonistas de neurokinina selectivos | |
EA201100094A1 (ru) | Тиадиазолилоксифениламидины и их применение в качестве фунгицидов | |
AR071673A1 (es) | Procedimiento para la preparacion de compuestos pirazolicos sustituidos en posiciones 1,3,4 | |
DE60143084D1 (de) | Verfahren zur herstellung von glyceriden mittels lipasen | |
EA201400230A1 (ru) | Фунгицидные замещенные 1-{2-[2-галоген-4-(4-галогенфенокси)фенил]-2-этоксиэтил}-1н-[1,2,4]триазольные соединения | |
AR042943A1 (es) | Insecticidas de ciano antranilamida | |
AR060489A1 (es) | Derivados del acido benzoazepin - oxi- acetico como agonistas de ppar - delta usados para aumentar hdl- c, reducir ldl-c y reducir colesterol | |
CO5700747A2 (es) | Piperidinas novedosas como moduladores de quimoquina (ccr) | |
ATE434609T1 (de) | Verfahren zur herstellung von 5-ä(r)-2-(5,6- diethyl-indan-2-ylamino)-1-hydroxyethylü-8- hydroxy-(1h)-chinolin-2-on-salzen, die sich als adrenozeptoragonisten eignen | |
AR087148A1 (es) | Imidazopiridazinas | |
DE502007004929D1 (de) | Verfahren zur umesterung von estern | |
MX2009006256A (es) | Composiciones intensificadoras inhibidoras de corrosion y metodos relacionados. | |
PE20100144A1 (es) | Compuestos quimicos 293 | |
ATE447567T1 (de) | Verfahren zur herstellung von tryptase- inhibitoren | |
PE20120223A1 (es) | Compuestos heterociclicos como inhibidores del transportador de glicina-1 (glyt-1) | |
EA201100594A1 (ru) | Триазольные и имидазольные соединения, их применение, а также содержащие их средства | |
ATE440815T1 (de) | Verfahren zur herstellung von dialkylcarbonaten | |
EA200802388A1 (ru) | Способ получения солифенацина | |
DE602005011804D1 (de) | Verfahren zur verbesserung der qualität von tierischem gewebe durch ergänzen der ration des tiers mit ölsäure und ausgewählten tocolen | |
RU2011127004A (ru) | Новые соединения | |
DE602005004557D1 (de) | Verfahren zur herstellung von mycophenolat-mofetil mittels enzymatischer umesterung | |
WO2003061652A8 (en) | 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors | |
WO2010070593A3 (en) | Malonate esters |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |